Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Insights into Imaging
Published in: Insights into Imaging 1/2019

Open Access 01-12-2019 | Meningioma | Review

Dural masses: meningiomas and their mimics

Authors: Daniel Lyndon, Joseph A. Lansley, Jane Evanson, Anant S. Krishnan

Published in: Insights into Imaging | Issue 1/2019

Login to get access

Abstract

Meningiomas are the most common dural tumour. They are regularly being seen as an incidental finding on brain imaging and treated conservatively. However, there are many other dural masses which mimic their appearances, including primary neoplastic processes, metastases, granulomatous diseases and infection. While some of these are rare, others such as metastases and tuberculosis arise relatively frequently in practice. Although not pathognomonic, key features which increase the probability of a lesion being a meningioma include intralesional calcifications, skull hyperostosis, local dural enhancement and increased perfusion. It is important to have an awareness of these entities as well as their main imaging findings, as they have a wide range of prognoses and differing management strategies. This review outlines several of the most important mimics along with their imaging findings on both standard and advanced techniques with key features which may be used to help differentiate them from meningiomas.
Literature
1.
Weber DC, Lovblad KO, Rogers L (2010) New pathology classification, imagery techniques and prospective trials for meningiomas: the future looks bright. Curr Opin Neurol 23(6):563–570PubMedCrossRef
2.
Ghosal N, Dadlani R, Gupta K, Furtado SV, Hegde AS (2012) A clinicopathological study of diagnostically challenging meningioma mimics. J Neurooncol 106(2):339–352PubMedCrossRef
3.
Laigle-Donadey F, Taillibert S, Mokhtari K, Hildebrand J, Delattre JY (2005) Dural metastases. J Neurooncol 75(1):57–61
4.
Cea-Soriano L, Wallander MA, García Rodríguez LA (2012) Epidemiology of meningioma in the United Kingdom. Neuroepidemiology 39(1):27–34PubMedCrossRef
5.
Louis DN, Perry A, Reifenberger G et al (2016) The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol 131(6):803–820PubMedCrossRef
6.
Backer-Grøndahl T, Moen BH, Torp SH (2012) The histopathological spectrum of human meningiomas. Int J Clin Exp Pathol 5(3):231–242PubMedPubMedCentral
7.
8.
Rodriguez D, Young Poussaint T (2004) Neuroimaging findings in neurofibromatosis type 1 and 2. Neuroimaging Clin N Am 14(2):149 –70–viiPubMedCrossRef
9.
Watts J, Box G, Galvin A, Brotchie P, Trost N, Sutherland T (2014) Magnetic resonance imaging of meningiomas: a pictorial review. Insights Imaging 5(1):113–122PubMedPubMedCentralCrossRef
10.
Buetow MP, Buetow PC, Smirniotopoulos JG (1991) Typical, atypical, and misleading features in meningioma. Radiographics 11(6):1087–1106PubMedCrossRef
11.
O'Leary S, Adams WM, Parrish RW, Mukonoweshuro W (2007) Atypical imaging appearances of intracranial meningiomas. Clin Radiol 62(1):10–17PubMedCrossRef
12.
Zeng L, Liang P, Jiao J, Chen J, Lei T (2015) Will an asymptomatic meningioma grow or not grow? A meta-analysis. J Neurol Surg A Cent Eur Neurosurg 76(5):341–347PubMedCrossRef
13.
Kim BW, Kim MS, Kim SW, Chang CH, Kim OL (2011) Peritumoral brain edema in meningiomas : correlation of radiologic and pathologic features. J Korean Neurosurg Soc 49(1):26–30PubMedPubMedCentralCrossRef
14.
Guermazi A, Lafitte F, Miaux Y, Adem C, Bonneville JF, Chiras J (2005) The dural tail sign--beyond meningioma. Clin Radiol 60(2):171–188PubMedCrossRef
15.
Zimny A, Sasiadek M (2010) Contribution of perfusion-weighted magnetic resonance imaging in the differentiation of meningiomas and other extra-axial tumors: case reports and literature review. J Neurooncol 103(3):777–783PubMedCentralCrossRef
16.
Kremer S, Grand S, Rémy C et al (2004) Contribution of dynamic contrast MR imaging to the differentiation between dural metastasis and meningioma. Neuroradiology 46(8):642–648PubMedCrossRef
17.
Cha S, Knopp EA, Johnson G, Wetzel SG, Litt AW, Zagzag D (2002) Intracranial mass lesions: dynamic contrast-enhanced susceptibility-weighted Echo-planar perfusion MR imaging. Radiology 223(1):11–29PubMedCrossRef
18.
Yue Q, Isobe T, Shibata Y et al (2008) New observations concerning the interpretation of magnetic resonance spectroscopy of meningioma. Eur Radiol 18(12):2901–2911PubMedCrossRef
19.
Bulakbasi N, Kocaoglu M, Ors F, Tayfun C, Uçöz T (2003) Combination of single-voxel proton MR spectroscopy and apparent diffusion coefficient calculation in the evaluation of common brain tumors. AJNR Am J Neuroradiol 24(2):225–233PubMedPubMedCentral
20.
Adams LC, Böker SM, Bender YY et al (2017) Assessment of intracranial meningioma-associated calcifications using susceptibility-weighted MRI. J Magn Reson Imaging 31:E19
21.
Sahm F, Reuss DE, Giannini C (2018) WHO 2016 Classification: changes and advancements in the diagnosis of miscellaneous primary CNS tumours. Neuropathol Appl Neurobiol 44(2):163-171
22.
Filippi CG, Edgar MA, Uluğ AM, Prowda JC, Heier LA, Zimmerman RD (2001) Appearance of meningiomas on diffusion-weighted images: correlating diffusion constants with histopathologic findings. AJNR Am J Neuroradiol 22(1):65–72PubMedPubMedCentral
23.
Herbst A, Mueller-Vogt U, Brawanski A, Proescholdt M, Riemenschneider MJ, Schebesch KM (2013) WHO grade III anaplastic meningioma metastasizing to the parotid gland and the lungs: case report and review of the literature. J Neurol Surg A Cent Eur Neurosurg 74(3):197–202PubMed
24.
Zhang H, Rödiger LA, Shen T, Miao J, Oudkerk M (2008) Perfusion MR imaging for differentiation of benign and malignant meningiomas. Neuroradiology 50(6):525–530PubMedPubMedCentralCrossRef
25.
Di Chiro G, Hatazawa J, Katz DA, Rizzoli HV, De Michele DJ (1987) Glucose utilization by intracranial meningiomas as an index of tumor aggressivity and probability of recurrence: a PET study. Radiology 164(2):521–526PubMedCrossRef
26.
Lee JW, Kang KW, Park SH et al (2009) 18F-FDG PET in the assessment of tumor grade and prediction of tumor recurrence in intracranial meningioma. Eur J Nucl Med Mol Imaging 36(10):1574–1582PubMedCrossRef
27.
Valotassiou V, Leondi A, Angelidis G, Psimadas D, Georgoulias P (2012) SPECT and PET imaging of meningiomas. ScientificWorldJournal 2012(1):1–11CrossRef
28.
29.
Oyoshi T, Nakayama M, Hirano H, Shimokawa S, Kuratsu J (2000) Intracranial dural metastasis of mediastinal seminoma—case report. Neurol Med Chir (Tokyo) 40(8):423–426CrossRef
30.
31.
Seki S, Kamide T, Tamase A, Mori K, Yanagimoto K, Nomura M (2016) Intraparenchymal hemorrhage from dural metastasis of breast cancer mimicking meningioma. Neuroradiol J 29(3):179–182PubMedPubMedCentralCrossRef
32.
Fink KR, Fink JR (2013) Imaging of brain metastases. Surg Neurol Int 4(5):209–212CrossRef
33.
Lui YW, Malhotra A, Farinhas JM et al (2011) Dynamic perfusion MRI characteristics of dural metastases and Meningiomas: a pilot study characterizing the first-pass wash-in phase beyond relative cerebral blood volume. AJR Am J Roentgenol 196(4):886–890PubMedCrossRef
34.
Erdogan H, Aydin MV, Tasdemiroglu E (2014) Tumor-to-tumor metastasis of the central nervous system. Turk Neurosurg 24(2):151–162PubMed
35.
Schweizer L, Koelsche C, Sahm F et al (2013) Meningeal hemangiopericytoma and solitary fibrous tumors carry the NAB2-STAT6 fusion and can be diagnosed by nuclear expression of STAT6 protein. Acta Neuropathol 125(5):651–658PubMedCrossRef
36.
Yalcin CE, Tihan T (2016) Solitary fibrous tumor/hemangiopericytoma dichotomy revisited: a restless family of neoplasms in the CNS. Adv Anat Pathol 23(2):104–111PubMedCrossRef
37.
Weon YC, Kim EY, Kim HJ, Byun HS, Park K, Kim JH (2007) Intracranial Solitary fibrous tumors: imaging findings in 6 consecutive patients. AJNR Am J Neuroradiol 28(8):1466-1469
38.
Bisceglia M, Galliani C, Giannatempo G et al (2011) Solitary fibrous tumor of the central nervous system: a 15-year literature survey of 220 cases (august 1996-July 2011). Adv Anat Pathol 18(5):356–392PubMedCrossRef
39.
Melone AG, D'Elia A, Santoro F et al (2014) Intracranial hemangiopericytoma—our experience in 30 years: a series of 43 cases and review of the literature. World Neurosurg 81(3–4):556–562PubMedCrossRef
40.
Schiariti M, Goetz P, El-Maghraby H, Tailor J, Kitchen N (2011) Hemangiopericytoma: long-term outcome revisited. Clinical article. J Neurosurg 114(3):747–755PubMedCrossRef
41.
Kinslow CJ, Rajpara RS, Wu CC et al (2017) Invasiveness is associated with metastasis and decreased survival in hemangiopericytoma of the central nervous system. J Neurooncol 25:514–519
42.
43.
Clarençon F, Bonneville F, Rousseau A et al (2011) Intracranial solitary fibrous tumor: imaging findings. Eur J Radiol 80(2):387–394PubMedCrossRef
44.
Zhou JL, Liu JL, Zhang J, Zhang M (2012) Thirty-nine cases of intracranial hemangiopericytoma and anaplastic hemangiopericytoma: a retrospective review of MRI features and pathological findings. Eur J Radiol 81(11):3504–3510PubMedCrossRef
45.
Akiyama M, Sakai H, Onoue H, Miyazaki Y, Abe T (2004) Imaging intracranial haemangiopericytomas: study of seven cases. Neuroradiology 46(3):194–197PubMedCrossRef
46.
Ma C, Xu F, Xiao YD, Paudel R, Sun Y, Xiao EH (2014) Magnetic resonance imaging of intracranial hemangiopericytoma and correlation with pathological findings. Oncol Lett 8(5):2140–2144PubMedPubMedCentralCrossRef
47.
Sibtain NA, Butt S, Connor SE (2007) Imaging features of central nervous system haemangiopericytomas. Eur Radiol 17(7):1685–1693PubMedCrossRef
48.
Rutten I, Raket D, Francotte N, Philippet P, Chao SL, Lemort M (2006) Contribution of NMR spectroscopy to the differential diagnosis of a recurrent cranial mass 7 years after irradiation for a pediatric ependymoma. Childs Nerv Syst 22(11):1475–1478PubMedCrossRef
49.
Hayashi S, Kurihara H, Hirato J, Sasaki T (2001) Solitary fibrous tumor of the orbit with extraorbital extension: case report. Neurosurgery 49(5):1241–1245PubMed
50.
Chan WS, Zhang J, Khong PL (2010) 18F-FDG-PET-CT imaging findings of recurrent intracranial haemangiopericytoma with distant metastases. Br J Radiol 83(992):e172–e174PubMedPubMedCentralCrossRef
51.
Yamada SM, Ikawa N, Toyonaga S, Nakabayashi H, Chang Park K, Shimizu K (2006) Primary malignant B-cell-type dural lymphoma: case report. Surg Neurol 66(5):539–543 discussion 543PubMedCrossRef
52.
Jahnke K, Schilling A, Heidenreich J et al (2005) Radiologic morphology of low-grade primary central nervous system lymphoma in immunocompetent patients. AJNR Am J Neuroradiol 26(10):2446–2454PubMedPubMedCentral
53.
Iwamoto FM, Abrey LE (2006) Primary dural lymphomas: a review. Neurosurg Focus 21(5):E5PubMed
54.
Freedman AS (2005) Biology and management of histologic transformation of indolent lymphoma. Hematology Am Soc Hematol Educ Program 2005(1):314–320CrossRef
55.
Hirmiz K, Foyle A, Wilke D et al (2004) Intracranial presentation of systemic Hodgkin’s disease. Leuk Lymphoma 45(8):1667–1671PubMedCrossRef
56.
Montoto S, Lister TA (2005) Secondary central nervous system lymphoma: risk factors and prophylaxis. Hematol Oncol Clin North Am 19(4):751–763 viiiPubMedCrossRef
57.
Haldorsen IS, Espeland A, Larsson EM (2011) Central nervous system lymphoma: characteristic findings on traditional and advanced imaging. AJNR Am J Neuroradiol 32(6):984–992PubMedCrossRefPubMedCentral
58.
Iwamoto FM, DeAngelis LM, Abrey LE (2006) Primary dural lymphomas: a clinicopathologic study of treatment and outcome in eight patients. Neurology 66(11):1763–1765PubMedCrossRef
59.
Ramnarayan R, Anilkumar T, Nayar R (2013) An unusual extra-axial hypodense lesion mimicking a chronic subdural haematoma. J Neurosci Rural Pract 4(2):216–219PubMedPubMedCentralCrossRef
60.
Gocmen S, Gamsizkan M, Onguru O, Sefali M, Erdogan E (2010) Primary dural lymphoma mimicking a subdural hematoma. J Clin Neurosci 17(3):380–382PubMedCrossRef
61.
da Rocha AJ, Sobreira Guedes BV, da Silveira da Rocha TM, Maia Junior AC, Chiattone CS (2016) Modern techniques of magnetic resonance in the evaluation of primary central nervous system lymphoma: contributions to the diagnosis and differential diagnosis. Rev Bras Hematol Hemoter 38: 44–54
62.
63.
64.
Palmedo H, Urbach H, Bender H et al (2006) FDG-PET in immunocompetent patients with primary central nervous system lymphoma: correlation with MRI and clinical follow-up. Eur J Nucl Med Mol Imaging 33(2):164–168PubMedCrossRef
65.
Ogawa T, Kanno I, Hatazawa J et al (1994) Methionine PET for follow-up of radiation therapy of primary lymphoma of the brain. Radiographics 14(1):101–110PubMedCrossRef
66.
67.
Rahimi-Movaghar V, Karimi M (2003) Meningeal melanocytoma of the brain and oculodermal melanocytosis (nevus of Ota): case report and literature review. Surg Neurol 59(3):200–210PubMedCrossRef
68.
Chen CJ, Hsu YI, Ho YS, Hsu YH, Wang LJ, Wong YC (1997) Intracranial meningeal melanocytoma: CT and MRI. Neuroradiology 39(11):811–814PubMedCrossRef
69.
Smith AB, Rushing EJ, Smirniotopoulos JG (2009) Pigmented lesions of the central nervous system: radiologic-pathologic correlation. Radiographics 29(5):1503–1524PubMedCrossRef
70.
Navas M, Pascual JM, Fraga J et al (2009) Intracranial intermediate-grade meningeal melanocytoma with increased cellular proliferative index: an illustrative case associated with a nevus of Ota. J Neurooncol 95(1):105–115PubMedCrossRef
71.
Unal B, Castillo M (2007) MRI features of a primary thoracic epidural melanoma: a case report. Clin Imaging 31(4):273–275PubMedCrossRef
72.
Soler C, Beauchesne P, Moncet M et al (1998) 99mTc-MIBI uptake in a primitive leptomeningeal melanoma. Eur J Dermatol 8(3):169–172PubMed
73.
Sagiuchi T, Ishii K, Utsuki S et al (2002) Increased uptake of technetium-99m-hexamethylpropyleneamine oxime related to primary leptomeningeal melanoma. AJNR Am J Neuroradiol 23(8):1404–1406PubMedPubMedCentral
74.
Tosaka M, Tamura M, Oriuchi N et al (2001) Cerebrospinal fluid immunocytochemical analysis and neuroimaging in the diagnosis of primary leptomeningeal melanoma. Case report. J Neurosurg 94(3):528–532PubMedCrossRef
75.
76.
Salvati M, Lenzi J, Brogna C et al (2006) Childhood’s gliosarcomas: pathological and therapeutical considerations on three cases and critical review of the literature. Childs Nerv Syst 22(10):1301–1306PubMedCrossRef
77.
Zhang BY, Chen H, Geng DY et al (2011) Computed tomography and magnetic resonance features of gliosarcoma: a study of 54 cases. J Comput Assist Tomogr 35(6):667–673PubMedCrossRef
78.
Moon SK, Kim EJ, Choi WS, Ryu CW, Park BJ, Lee J (2010) Gliosarcoma of the cerebellar hemisphere: a case report and review of the literature. Korean J Radiol 11(5):566–565PubMedPubMedCentralCrossRef
79.
Andriko JA, Morrison A, Colegial CH, Davis BJ, Jones RV (2001) Rosai-Dorfman disease isolated to the central nervous system: a report of 11 cases. Mod Pathol 14(3):172–178PubMedCrossRef
80.
Huang BY, Zong M, Zong WJ, Sun YH, Zhang H, Zhang HB (2016) Intracranial Rosai-Dorfman disease. J Clin Neurosci 32:133–136PubMedCrossRef
81.
Foucar E, Rosai J, Dorfman R (1990) Sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease): review of the entity. Semin Diagn Pathol 7(1):19–73PubMed
82.
Raslan OA, Schellingerhout D, Fuller GN, Ketonen LM (2011) Rosai-Dorfman disease in neuroradiology: imaging findings in a series of 10 patients. AJR Am J Roentgenol 196(2):W187–W193PubMedCrossRef
83.
Baruah D, Guleria S, Chandra T, Kumar R, Jain SK (2007) Rosai–Dorfmann disease with extensive extra nodal involvement. Eur J Radiol Extra 62(1):31–33CrossRef
84.
Adeleye AO, Amir G, Fraifeld S, Shoshan Y, Umansky F, Spektor S (2013) Diagnosis and management of Rosai–Dorfman disease involving the central nervous system. Neurol Res 32(6):572–578CrossRef
85.
Gabbay LB, Leite Cda C, Andriola RS, Pinho Pda C, Lucato LT (2014) Histiocytosis: a review focusing on neuroimaging findings. Arq Neuropsiquiatr 72(7):548–558PubMedCrossRef
86.
Diamond EL, Dagna L, Hyman DM et al (2014) Consensus guidelines for the diagnosis and clinical management of Erdheim-Chester disease. Blood 124(4):483–492PubMedPubMedCentralCrossRef
87.
Veyssier-Belot C, Cacoub P, Caparros-Lefebvre D et al (1996) Erdheim-Chester disease. Clinical and radiologic characteristics of 59 cases. Medicine (Baltimore) 75(3):157–169CrossRef
88.
Lachenal F, Cotton F, Desmurs-Clavel H et al (2006) Neurological manifestations and neuroradiological presentation of Erdheim-Chester disease: report of 6 cases and systematic review of the literature. J Neurol 253(10):1267–1277PubMedCrossRef
89.
Drier A, Haroche J, Savatovsky J et al (2010) Cerebral, facial, and orbital involvement in Erdheim-Chester disease: CT and MR imaging findings. Radiology 255(2):586–594PubMedCrossRef
90.
Tien RD, Brasch RC, Jackson DE, Dillon WP (1989) Cerebral Erdheim-Chester disease: persistent enhancement with Gd-DTPA on MR images. Radiology 172(3):791–792PubMedCrossRef
91.
Pareek M, Greenaway C, Noori T, Munoz J, Zenner D (2016) The impact of migration on tuberculosis epidemiology and control in high-income countries: a review. BMC Med 14(1):48PubMedPubMedCentralCrossRef
92.
Rajajee S, Narayanan PR (1992) Immunological spectrum of childhood tuberculosis. J Trop Pediatr 38(1):31–33PubMedCrossRef
93.
Aggarwal A, Patra DP, Gupta K, Sodhi HB (2016) Dural tuberculoma mimicking meningioma: a clinicoradiologic review of dural en-plaque lesions. World Neurosurg 88:686.e1–686.e7CrossRef
94.
Donald PR, Schaaf HS, Schoeman JF (2005) Tuberculous meningitis and miliary tuberculosis: the Rich focus revisited. J Infect 50(3):193–195PubMedCrossRef
95.
Patkar D, Narang J, Yanamandala R, Lawande M, Shah GV (2012) Central nervous system tuberculosis: pathophysiology and imaging findings. Neuroimaging Clin N Am 22(4):677–705PubMedCrossRef
96.
Shukla R, Abbas A, Kumar P, Gupta RK, Jha S, Prasad KN (2008) Evaluation of cerebral infarction in tuberculous meningitis by diffusion weighted imaging. J Infect 57(4):298–306PubMedCrossRef
97.
Villoria MF, de la Torre J, Fortea F, Munoz L, Hernandez T, Alarcón JJ (1992) Intracranial tuberculosis in AIDS: CT and MRI findings. Neuroradiology 34(1):11–14PubMedCrossRef
98.
Elisevich K, Arpin EJ (1982) Tuberculoma masquerading as a meningioma. Case report. J Neurosurg 56(3):435–438PubMedCrossRef
99.
Adachi K, Yoshida K, Tomita H, Niimi M, Kawase T (2004) Tuberculoma mimicking falx meningioma--case report. Neurol Med Chir (Tokyo) 44(9):489–492CrossRef
100.
Boutarbouch M, Arkha Y, Gana R, El Maquili MR, Bellakhdar F (2009) Tuberculoma of the cavernous sinus mimicking a meningioma: case report and review of the literature. J Neurol Sci 278(1–2):123–126PubMedCrossRef
101.
Srikanth SG, Taly AB, Nagarajan K, Jayakumar PN, Patil S (2007) Clinicoradiological features of tuberculous meningitis in patients over 50 years of age. J Neurol Neurosurg Psychiatry 78(5):536–538PubMedCrossRef
102.
Khanna PC, Godinho S, Patkar DP, Pungavkar SA, Lawande MA (2006) MR spectroscopy-aided differentiation: “giant” extra-axial tuberculoma masquerading as meningioma. AJNR Am J Neuroradiol 27(7):1438–1440PubMedPubMedCentral
103.
Chatterjee S, Saini J, Kesavadas C, Arvinda HR, Jolappara M, Gupta AK (2010) Differentiation of tubercular infection and metastasis presenting as ring enhancing lesion by diffusion and perfusion magnetic resonance imaging. J Neuroradiol 37(3):167–171PubMedCrossRef
104.
Fragoulis GE, Lionaki S, Venetsanopoulou A, Vlachoyiannopoulos PG, Moutsopoulos HM, Tzioufas AG (2018) Central nervous system involvement in patients with granulomatosis with polyangiitis: a single-center retrospective study. Clin Rheumatol 37(3):737–747PubMedCrossRef
105.
Borner U, Landis BN, Banz Y et al (2012) Diagnostic value of biopsies in identifying cytoplasmic antineutrophil cytoplasmic antibody-negative localized Wegener’s granulomatosis presenting primarily with sinonasal disease. Am J Rhinol Allergy 26(6):475–480PubMedCrossRef
106.
Di Comite G, Bozzolo EP, Praderio L, Tresoldi M, Sabbadini MG (2006) Meningeal involvement in Wegener's granulomatosis is associated with localized disease. Clin Exp Rheumatol 24(2 Suppl 41):S60–S64PubMed
107.
Murphy JM, Gomez-Anson B, Gillard JH et al (1999) Wegener granulomatosis: MR imaging findings in brain and meninges. Radiology 213(3):794–799PubMedCrossRef
108.
109.
Pakalniskis MG, Berg AD, Policeni BA et al (2015) The many faces of granulomatosis with polyangiitis: a review of the head and neck imaging manifestations. Am J Roentgenol 205(6):W619–W629
110.
Berlis A, Petschner F, Bötefür IC, Spreer J (2003) Wegener granuloma in the fourth ventricle. AJNR Am J Neuroradiol 24(3):523–525
111.
Purgina B, Rao UNM, Miettinen M, Pantanowitz L (2011) AIDS-related EBV-associated smooth muscle tumors: a review of 64 published cases. Patholog Res Int 2011(2):1–10
112.
Lohan R, Bathla G, Gupta S, Hegde AN (2013) Epstein–Barr virus (EBV)-related smooth muscle tumors of central nervous system—a report of two cases and review of literature. Clin Imaging 37(3):564–568PubMedCrossRef
113.
Moore Dalal K, Antonescu CR, DeMatteo RP, Maki RG (2008) EBV-associated smooth muscle neoplasms: solid tumors arising in the presence of immunosuppression and autoimmune diseases. Sarcoma 2008(1):1–6CrossRef
114.
Hamano H, Kawa S, Horiuchi A et al (2001) High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med 344(10):732–738PubMedCrossRef
115.
Thompson A, Whyte A (2018) Imaging of IgG4-related disease of the head and neck. Clin Radiol 73(1):106–120PubMedCrossRef
116.
Wong S, Lam WY, Wong WK, Lee KC (2007) Hypophysitis presented as inflammatory pseudotumor in immunoglobulin G4-related systemic disease. Hum Pathol 38(11):1720–1723PubMedCrossRef
117.
Lindstrom KM, Cousar JB, Lopes MBS (2010) IgG4-related meningeal disease: clinico-pathological features and proposal for diagnostic criteria. Acta Neuropathol 120(6):765–776PubMedCrossRef
118.
119.
120.
Lu LX, Della-Torre E, Stone JH, Clark SW (2014) IgG4-related hypertrophic pachymeningitis: clinical features, diagnostic criteria, and treatment. JAMA Neurol 71(6):785–793PubMedCrossRef
121.
Lee YS, Lee HW, Park KS, Park SH, Hwang JH (2014) Immunoglobulin g4-related hypertrophic pachymeningitis with skull involvement. Brain Tumor Res Treat 2(2):87–91PubMedPubMedCentralCrossRef
122.
Katsura M, Mori H, Kunimatsu A et al (2012) Radiological features of IgG4-related disease in the head, neck, and brain. Neuroradiology 54(8):873–882PubMedCrossRef
123.
Martínez-de-Alegría A, Baleato-González S, García-Figueiras R et al (2015) IgG4-related disease from head to toe. Radiographics 35(7):2007–2025PubMedCrossRef
124.
Lu LX, Della-Torre E, Stone JH, Clark SW (2014) IgG4-related hypertrophic Pachymeningitis. JAMA Neurol 71(6):785–789PubMedCrossRef
125.
Norikane T, Yamamoto Y, Okada M et al (2012) Hypertrophic cranial pachymeningitis with IgG4-positive plasma cells detected by C-11 methionine PET. Clin Nucl Med 37(1):108–109PubMedCrossRef
Metadata
Title
Dural masses: meningiomas and their mimics
Authors
Daniel Lyndon
Joseph A. Lansley
Jane Evanson
Anant S. Krishnan
Publication date
01-12-2019
Publisher
Springer Berlin Heidelberg
Published in
Insights into Imaging / Issue 1/2019
Electronic ISSN: 1869-4101
DOI
https://doi.org/10.1186/s13244-019-0697-7

Other articles of this Issue 1/2019

Insights into Imaging 1/2019 Go to the issue

Pictorial Review

Pathophysiology of right ventricular failure in acute pulmonary embolism and chronic thromboembolic pulmonary hypertension: a pictorial essay for the interventional radiologist

Educational Review

Role of imaging in the evaluation of vascular complications after liver transplantation

Pictorial Review

Imaging in the diagnosis of ulnar nerve pathologies—a neoteric approach

Review

Thyroglossal duct pathology and mimics

Critical Review

Diagnostic value of alternative techniques to gadolinium-based contrast agents in MR neuroimaging—a comprehensive overview

Pictorial Review

Response evaluation after neoadjuvant treatment for rectal cancer using modern MR imaging: a pictorial review